High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
about
The Meiotic Recombination Activator PRDM9 Trimethylates Both H3K36 and H3K4 at Recombination Hotspots In VivoSETD2: an epigenetic modifier with tumor suppressor functionalityGenomic aberrations frequently alter chromatin regulatory genes in chordoma.A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.l-Arginine-Dependent Epigenetic Regulation of Interleukin-10, but Not Transforming Growth Factor-β, Production by Neonatal Regulatory T LymphocytesLoss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific deathDecreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma.Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma.Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.Dual Chromatin and Cytoskeletal Remodeling by SETD2.Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma.Writing, erasing and reading histone lysine methylations.Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma.Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.Methylated α-tubulin antibodies recognize a new microtubule modification on mitotic microtubules.Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.Loss of Chromatin Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma.SETD2 mutations in primary central nervous system tumors
P2860
Q27308664-4AFC485D-2036-44A1-9BE7-59AB2ED072BBQ28075731-0C3B095C-014F-4D43-8B0B-FD95F8352B0BQ33275983-0BB2F69A-2B1B-4CE8-AFDD-DD5D7F892CE2Q33457518-BA75B3F5-8206-4AEF-8A9C-12B78A8847F7Q33599841-1A0B9ECD-45DB-41BB-BA90-28E7CA2FF730Q36420712-10E4B1AE-5991-48D7-A606-B66FA1C62874Q37016755-AB9B5C40-43F1-4759-9B7B-140A0B285C53Q37257158-CF814C05-081C-4A56-A46D-D5DA582680CFQ38273214-8C3F43D2-4E87-415C-85A1-97BB2D980862Q38655126-ED0FE64E-F933-461B-9A65-3EAF82AA7F94Q38752272-2F694228-E775-4BCC-8D91-AC48441371DDQ38813611-5F03700E-E555-4CBD-858D-71CFF70E18AEQ39268171-FFFB0391-5658-4B7B-A0F4-EE68DEC9C078Q39608223-1B1C142F-A1CA-454E-879F-64EF28A312BFQ40243097-0C77B669-BE49-4E3A-AC30-C3F3D6F8EF2EQ41472320-E84B0EAE-4504-48A9-97BC-8760977C2FB2Q41574276-9C1DAABB-F633-405F-9378-A79B64753796Q41856051-28B13AF9-E600-4BB6-974B-E360F43CED93Q47252459-3C9B1D5C-5283-47E8-8A84-1CB291A201F1Q52688905-B637F2A8-09A2-414D-A6D4-68A62CE4A48CQ55172634-4AE4C884-F7D7-42C0-902B-F6EE7881AEF6Q59136863-302C744E-3F2D-4912-8279-BCC07F25E8F9
P2860
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
High-resolution profiling of h ...... tastatic renal cell carcinoma.
@ast
High-resolution profiling of h ...... tastatic renal cell carcinoma.
@en
type
label
High-resolution profiling of h ...... tastatic renal cell carcinoma.
@ast
High-resolution profiling of h ...... tastatic renal cell carcinoma.
@en
prefLabel
High-resolution profiling of h ...... tastatic renal cell carcinoma.
@ast
High-resolution profiling of h ...... tastatic renal cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
High-resolution profiling of h ...... tastatic renal cell carcinoma.
@en
P2093
A S Parker
C L Walker
E P Castle
F A Monzon
P2860
P2888
P304
P356
10.1038/ONC.2015.221
P407
P577
2015-06-15T00:00:00Z
P5875
P6179
1001873655